SPECTRAL MEDICAL INC (EDT.CA) Stock Price, Forecast & Analysis
Canada - TSX:EDT - CA8475771033 - Common Stock
EDT.CA Key Statistics, Chart & Performance
The current stock price of EDT.CA is 1.48 CAD. In the past month the price increased by 8.03%. In the past year, price increased by 150.85%.
EDT.CA Latest News, Press Relases and Analysis
EDT.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 404.80M | ||
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 322.55M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 152.76M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 123.45M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 28.63 | 62.79M | ||
| NRX.CA | NUREXONE BIOLOGIC INC | N/A | 57.76M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | N/A | 34.88M | ||
| BCT.CA | BRIACELL THERAPEUTICS CORP | N/A | 28.82M | ||
| RVX.CA | RESVERLOGIX CORP | N/A | 27.24M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 18.40M | ||
| MPH.CA | MEDICURE INC | N/A | 12.11M | ||
| CSCI.CA | COSCIENS BIOPHARMA INC | N/A | 11.34M |
Related stock screener links
About EDT.CA
Company Profile
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The firm also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. The company provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
Company Info
SPECTRAL MEDICAL INC
135 The West Mall, Unit 2
TORONTO ONTARIO M9C 1C2 CA
CEO: Chris Seto
Employees: 29
Phone: 14166263233
SPECTRAL MEDICAL INC / EDT.CA FAQ
What does SPECTRAL MEDICAL INC do?
Spectral Medical, Inc. engages in the development and commercialization of therapeutic treatment for septic shock. The company is headquartered in Toronto, Ontario and currently employs 29 full-time employees. The firm develops and commercializes Toraymyxin (PMX), a therapeutic hemoperfusion device designed to remove endotoxins from the bloodstream, which are a major cause of sepsis. The firm also offers the Endotoxin Activity Assay (EAA), the diagnostic test for detecting endotoxin levels in blood, and it provides an endotoxin activity result normally between 0.0 and 1.0. The company provides reagents for both research and commercial applications. Their product line includes monoclonal antibodies and recombinant proteins, which are essential for developing advanced diagnostic tools. Additionally, the Company is conducting the Tigris Clinical Trial, a confirmatory study evaluating PMX in combination with standard care versus standard care alone, using Bayesian statistical analysis.
What is the stock price of SPECTRAL MEDICAL INC today?
The current stock price of EDT.CA is 1.48 CAD. The price decreased by -1.99% in the last trading session.
Does EDT stock pay dividends?
EDT.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of EDT stock?
EDT.CA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Where is SPECTRAL MEDICAL INC (EDT.CA) stock traded?
EDT.CA stock is listed on the Toronto Stock Exchange exchange.
Can you provide the sector and industry classification for SPECTRAL MEDICAL INC?
SPECTRAL MEDICAL INC (EDT.CA) operates in the Health Care sector and the Biotechnology industry.
What is the market capitalization of EDT stock?
SPECTRAL MEDICAL INC (EDT.CA) has a market capitalization of 426.15M CAD. This makes EDT.CA a Small Cap stock.
EDT.CA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to EDT.CA. When comparing the yearly performance of all stocks, EDT.CA is one of the better performing stocks in the market, outperforming 92.79% of all stocks.
EDT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to EDT.CA. EDT.CA may be in some trouble as it scores bad on both profitability and health.
EDT.CA Financial Highlights
Over the last trailing twelve months EDT.CA reported a non-GAAP Earnings per Share(EPS) of -0.08. The EPS decreased by -17.97% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -388.99% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
EDT.CA Forecast & Estimates
5 analysts have analysed EDT.CA and the average price target is 3.16 CAD. This implies a price increase of 113.65% is expected in the next year compared to the current price of 1.48.
For the next year, analysts expect an EPS growth of 57.14% and a revenue growth 14.29% for EDT.CA